Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-186177
Filing Date
2019-06-28
Accepted
2019-06-28 17:01:26
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d40667d424b5.htm 424B5 400255
2 GRAPHIC g40667g0425153600926.jpg GRAPHIC 2869
3 GRAPHIC g40667g0518081947334.jpg GRAPHIC 2922
4 GRAPHIC g40667g0518081947506x192.jpg GRAPHIC 3076
  Complete submission text file 0001193125-19-186177.txt   414139
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-217459 | Film No.: 19930215
SIC: 2835 In Vitro & In Vivo Diagnostic Substances